Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 19 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (7)
P 1 (4)
P 2 (3)
P 3 (1)

Trial Status

Unknown8
Completed8
Recruiting2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT05359653Phase 1Recruiting

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

NCT07280871Not Yet Recruiting

Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care

NCT05964829Not ApplicableRecruiting

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

NCT05496881Not ApplicableUnknown

Exercise Effects in Multiple Sclerosis

NCT03799718Phase 2CompletedPrimary

Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS

NCT02903537Phase 1Unknown

Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)

NCT05562414Not ApplicableUnknownPrimary

Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis

NCT05385731Not ApplicableUnknownPrimary

MUSCLE - Nordic Walking in MUltiple SCLErosis

NCT04550650Not ApplicableCompletedPrimary

Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients

NCT04993274Unknown

Sensitivity of Motor Assessment in MS - a Prospective Cohort Study

NCT02403570Completed

Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis

NCT03424538Not ApplicableCompletedPrimary

The Effect of Neurorehabilitation Therapy on Postural Control, Mobility and Quality of Life in Multiple Sclerosis Patients

NCT02545959Phase 2CompletedPrimary

Intrathecal Rituximab in Progressive Multiple Sclerosis

NCT03114293Not ApplicableUnknownPrimary

Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS

NCT01188811Phase 2CompletedPrimary

Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)

NCT01436838CompletedPrimary

China Betaferon Adherence, Coping and Nurse Support Study

NCT00241254Phase 3CompletedPrimary

Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis

NCT00411723Phase 1UnknownPrimary

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

NCT00220493Phase 1Unknown

Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients

Showing all 19 trials

Research Network

Activity Timeline